Tagged with B

Biopark Charleroi Brussels South Could you tell our readers who are not familiar with the Biopark with an introduction of the Biopark and its institutes? The BioPark of Charleroi Brussels South is a campus where major biomedical research infrastructures of the Université Libre de Bruxelles (ULB) have been established since 1999. It was a…

Mylan - Belgium The generics market in Belgium doesn’t seem to be at the level it deserves to be. Considering that Mylan controls about 14% of the local generics market share, how would you assess the authorities and physicians attitude towards the generic drugs in Belgium? In Belgium, generic drugs are not being…

Boehringer Ingelheim Austria Austria has always been a strategic market for the group: it has played a key role in Boehringer Ingelheim’s success story, as this is where the company established its first foreign subsidiary in 1948. Can you give our readers a snapshot of the strategic importance Austria has today for the…

Business & Decision Life Sciences Business & Decision Life Science was founded back in 2007, although that department existed within the group’s structure long before that. Could you highlight the reasons why a special business unit dedicated to the life sciences industry needed to be created back in 2007? Founded in 1992, Business & Decisions…

Sanofi - Belgium Mr Hendrickx, considering that you have been with Sanofi for over a decade, what would you describe as the single most important change in Sanofi’s business model? In essence, it is the diversification of Sanofi into a wide range of business activities. In the past, Sanofi was very successful at…

Bacher Zoppi Mexico Could you please Introduce BacherZoppi’s history, vision and main milestones to our readers? The company was founded in 1996, initially as a human resources service provider for pharmaceutical sales forces in Mexico. We quickly realized that the future of our business would be commercial business process outsourcing (BPO). This is…

convatec Convatec acquired Boston Medical Device in September 2011. Which have been the major challenges following the acquisition, and which synergies are to be expected? The story of BMD would suffice for several volumes, as it has been a long and winding road. We have experienced several transitions in the last…

Becton Dickinson & Co Central Asia, what is Central Asia in the BD perspective? For us, Central Asia includes all the countries in Asia, except Greater China, India and Japan. What have been the main developments in BD since its establishment in Singapore? BD has been in Singapore since the late 1980s with an…

ireland Mr. Mazeman, can you please begin by offering a brief overview of your career to date? I am a French pharmacist by training, with expertise in pharmacology. I have worked for Servier for my entire career. I started in the industry as a medical representative for the company. I went…

China One of the earliest innovative biotech companies in China, Zensun has developed what its founder Dr. Zhou Mingdong calls a rare made-in-China first-in-class therapeutic candidate, Neucardin®, which has been shown to improve cardiac function, quality of life and exercise capability, and, to reduce all-cause mortality rates in certain patients suffering…

Eurogentec Belgium Mr Delwart, you have been acting CEO of EuroGenTec for an impressive 19 years. During your tenure, what would you say has been the single most important change in the business model of the life sciences industry? The pharmaceutical industry is increasingly being under pressure by the rising costs of…

Baxter Mexico Baxter established itself in Mexico as early as 1948 through the acquisition of a local manufacturer, Madom’s Pharmaceutical. In a vast market like France, operations started 40 years ago; in Chile, operations started only in 1995; how do you explain the very early focus on Mexico? Mexico has always been…